Please login to the form below

Not currently logged in
Email:
Password:

dosing

This page shows the latest dosing news and features for those working in and with pharma, biotech and healthcare.

New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses

New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses

Enspryng is the first and only NMOSD treatment administered subcutaneously every four weeks, allowing for home-dosing and increasing flexibility.

Latest news

More from news
Approximately 3 fully matching, plus 515 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....